CAR-T Therapy Development on the Rise
2 New Studies Emphasize CRISPR Off-Target Edits and Imperfections
In gene editing milestone, first patient treated in Vertex, CRISPR Therapeutics study
7 Diseases CRISPR Technology Could Cure
5 Biopharma Trends to Watch in 2019
Τop Advances in 2018 That Are Shaping Medicine
Are China’s CRISPR Clinical Trials Running off the Rails?
Biopharma in 2019
Is the Biotech Bull Market Over?
FDA Lifts Clinical Hold; Green-Lights Vertex and CRISPR’s Sickle Cell Gene Therapy Trial
FDA clears Vertex, CRISPR to test gene-editing therapy in sickle cell patients
Amicus muscles in on Pompe gene therapy chase
Gene therapy deal-making shows no signs of stopping
CRISPR Therapeutics and ViaCyte Collaborate to Tackle Type 1 Diabetes
US Companies Launch CRISPR Clinical Trial
CRISPR, Vertex launch first company-backed gene editing trial in humans